Receptor specific macrophage targeting by mannose-conjugated gelatin nanoparticles- an in Vitro and in Vivo study

Current Nanoscience

Volumn 6, Issue 4, 2010, Pages 413-421

  Mahajan, Shveta ^a   Prashant, C K ^b   Koul, Veena ^a   Choudhary, Veena ^a   Dinda, Amit K ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Biocompatibility; Biodistribution; Gelatin nanoparticles; In vitro uptake; Macrophage targeting; Mannosylation

Indexed keywords

BIODISTRIBUTION; GELATIN NANOPARTICLES; IN-VITRO; MACROPHAGE TARGETING; MANNOSYLATION;

BIOCOMPATIBILITY; CONFOCAL MICROSCOPY; DRUG DELIVERY; MACROPHAGES; POLYDISPERSITY; TISSUE;

NANOPARTICLES;

DRUG CARRIER; GELATIN; MANNOSE; MANNOSE RECEPTOR; NANOPARTICLE; STAVUDINE;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CELL LINE; DRUG RELEASE; INTERNALIZATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REACTION ANALYSIS; RETICULOENDOTHELIAL SYSTEM; SYNTHESIS;

MURINAE;

EID: 79951926169     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/157341310791658928     Document Type: Article

References (37)

1. Lipscomb, M. F.; Russell, S. W. Lung macrophages and dendritic cells in health and disease, Marcel-Dekker, Inc.: New York, 1997.
2. Brain, J. D. Macrophage damage in relation to the pathogenesis of lung diseases. Environ. Health Persp., 1980, 35, 21-28.
3. Chanwong, S.; Maneekarn, N.; Makonkawkeyoon, L.; S. Makonkawkeyoon, S. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages. Tuberculosis, 2007, 87, 130-133.
4. Alexander, J.; Russell, D. G. The interaction of Leishmania species with macrophages. Adv. Parasitol., 1992, 31, 175-254.
5. Kima, P.E. The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist. Int. J. Parasitol., 2007, 37, 1087-1096.
6. Vladoianu, I-R.; Hernan, R.C.; Pechere, J-C. Expression of host resistance to salmonella typhi and Salmonella typhimurium: Bacterial survival within macrophages of murine and human origin. Microb. Pathogenesis, 1990, 8, 83-90.
7. Werneck-barroso, E.; Da, M.; Bonecini-de-Almeida, G.; Vieira, M. A. M. S.; Carvalho, C. E.; Teixeira, A. K.; Kritski, A. L.; Ho, J. L. Preferential recruitment of phagocytes into the lung of patients with advanced acquired immunodeficiency syndrome and tuberculosis. Respir. Med., 2000, 94, 64-70.
8. Gordon, S.; Rabinowitz, S. Macrophages as targets for drug delivery. Adv. Drug Deliv. Rev., 1989, 4, 27-47.
9. Ahsan, F.; Rivas, I. P.; Khan, M. A.; Suarez, A. I. T. Targeting to macrophages: Role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J. Control. Release, 2002, 79, 29-40.
10. Chellat, F.; Merhi, Y.; Moreau, A.; Yahia, L'H. Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials, 2005, 26, 7260-7275.
11. Balland, O.; Pinto-Alphandary, H.; Viron, A.; Puvion, E.; Andremont, A.; Couvreur, P. Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H) ampicillin loaded nanoparticles. J. Antimicrob. Chemother., 1996, 37, 105-115.
12. Espuelas, M. S.; Legrand, P.; Loiseau, P. M.; Bories, C.; Barratt, G.; Irache, J. M. In vitro antileishmanial activity of amphotericin B loaded in poly(ε- caprolactone) nanospheres. J. Drug Target., 2002, 10, 593-599.
13. Broz, P.; Marsch, S.; Hunziker, P. Targeting of vulnerable plaque macrophages with polymer-based nanostructures. Trends Cardiovasc. Med., 2007, 17, 190-196.
14. Tomoda, K.; Makino, K. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres. Colloids Surf. B Biointerf., 2007, 55, 115-124.
15. Tabata, Y.; Ikada, Y. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials, 1988, 9, 356-362.
16. Seno, S.; Tanaka, A.; Urata, M.; Hirata, K.; Nakatsuka, H.; Yamamoto, S. Phagocytic response of rat liver capillary endothelial cells and Kupffer cells to positive and negative charged iron colloid particles. Cell Struct. Funct., 1975, 1, 119-l 27.
17. Wijagkanalan, W.; Kawakami, S.; Takenaga, M.; Igarashi, R.; Yamashita, F. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J. Control. Release, 2008, 125, 121-130.
18. Park, K.-H.; Sung, W. J.; Kim, S.; Kim, D. H.; Akaike, T.; Chung, H.-M. Specific interaction of mannosylated glycopolymers with macrophage cells mediated by mannose receptor. J. Biosci. Bioeng., 2005, 99, 285-289.
19. Yeeprae, W.; Kawakami, S.; Yamashita, F.; Hashida, M. Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages. J. Control. Release, 2006, 114, 193-201.
20. Haensler, J.; Schuber, F. Preparation of neo-galactosylated liposomes andtheir interaction with mouse peritoneal macrophages. Biochim. Biophys. Acta, 1988, 946, 95-105.
21. Stahl, P. D. The mannose receptor and other macrophage lectins. Curr. Opin. Immunol., 1992, 4, 49-52.
22. Fraser, I. P.; Koziel, H.; Ezekowitz, R. A. B. The serum mannose-binding protein and the macrophage mannose receptor are pattern recognition molecules that link innate and adaptive immunity. Semin. Immunol., 1998, 10, 363-372.
23. Stahl, P.; Gordon, S. Expression of a mannosyl-fucosyl receptor for endocytosis on cultured primary macrophages and their hybrids. J. Cell Biol., 1982, 93, 49-56.
24. Tabata, Y.; Ikada, Y. Targeting of muramyl dipeptide to macrophages by gelatin conjugation to enhance their in vivo antitumor activity. J. Control. Release, 1993, 27, 79-88.
25. Tabata, Y.; Ikada, Y. Synthesis of gelatin microspheres containing interferon. Pharm. Res., 1994, 6, 422-427.
26. Tabata, Y.; Hijikata, S.; Muniruzzaman, M.; Ikada, Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J. Biomater. Sci. Polym. Ed., 1999, 10, 79-94.
27. Truong-Le, V. L.; August, J. T.; Leong, K. W. Controlled gene delivery by DNA-gelatin nanospheres. Hum. Gene Ther., 1998, 9, 1709-1717.
28. Li, J. K.; Wang, N.; Wu, X. S. A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery. J. Pharm. Sci., 1997, 86, 891-895.
29. Kaul, G.; Amiji, M. Long-circulating poly(ethyleneglycol)-modified gelatin nanoparticles for intracellular delivery. Pharm. Res. 2002, 19, 1061-1067.
30. Mladenovska, K.; Kumbaradzi, E. F.; Dodov, G. M.; Makraduli, L.; Goracinova, K. Biodegradation and drug release studies of BSA loaded gelatin microspheres. Int. J. Pharm., 2002, 242, 247-249.
31. Marty, J. J.; Oppenheim, R. C.; Speiser, P. Nanoparticles- A new colloidal drug delivery system. Pharm. Acta Helv., 1978, 53, 17-23.
32. Coester, C. J.; Langer, K.; von Briesen, H.; Kreuter, J. Gelatin nanoparticles by two step desolvation- A new preparation method, surface modifications and cell uptake. J. Microencapsulation, 2000, 17, 187-193.
33. Sehgal, D.; Vijay, I. K. A method for the high efficiency of water soluble carbodiimide-mediated amidation. Anal. Biochem., 1994, 218, 87-91.
34. Zhao, J.; Bowman, L.; Zhang, X.; Shi, X.; Jiang, B.; Castranova, V.; Ding, M. Metallic nickel nano- and fine particles induce JB6 cell apoptosis through a caspase-8/AIF mediated cytochrome c-independent pathway. J. Nanobiotechnol., 2009, 7, 2.
35. Jung, E. M.; Lim, J. H.; Lee, T. J.; Park, J. W.; Choi, K. S.; Kwon, T. K. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis, 2005, 26, 1905-1913.
36. Narang, D.; Sood, S.; Thomas, M. K.; Dinda, A. K.; Maulik, S. K. Effect of dietary palm olein oil on oxidative stress associated with ischemicreperfusion injury in isolated rat heart. BMC Pharmacol., 2004, 9(4), 29.
37. Wine, Y.; Cohen-Hadar, N.; Freeman, A.; Frolow, F. Elucidation of the mechanism and end products of glutaraldehyde crosslinking reaction by Xray structure analysis. Biotechnol. Bioeng., 2007, 98, 711-718.